Skip to main content

Table 4 Factors associated with disease progression in patients with nontuberculous mycobacterial pulmonary disease

From: Clinical course of nontuberculous mycobacterial pulmonary disease in patients with rheumatoid arthritis

 

Univariate analysis

Multivariate analysis

HR (95% CI)

P-value

adjusted HR (95% CI)

P-value

Age, years

0.98 (0.95–1.01)

0.190

0.97 (0.94–0.99)

0.038

Male sex

1.73 (0.78–3.86)

0.180

0.91 (0.36–2.32)

0.846

Body mass index, kg/m2

0.97 (0.86–1.09)

0.571

  

Former or current smoking

0.96 (0.35–2.67)

0.941

  

Comorbidities

    

 History of tuberculosis

1.20 (0.70–2.07)

0.500

  

 Diabetes

1.06 (0.39–2.92)

0.917

  

 Chronic obstructive pulmonary disease

1.37 (0.43–4.38)

0.360

  

 Malignancy

0.89 (0.38–2.08)

0.792

  

 Rheumatoid arthritis

1.42 (0.72–2.82)

0.319

  

AFB smear positivity

2.03 (1.13–3.64)

0.018

2.65 (1.41-5.00)

0.003

M. abscessus versus M. avium complex

1.46 (0.73–2.89)

0.283

  

Presence of cavity

2.23 (1.28–3.85)

0.004

2.45 (1.30–4.60)

0.006

  1. AFB, acid fast bacilli; HR, hazard ratio